MECOM and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, RUNX1-EVI1 is a secondary mutation found in secondary AML and in CML in blast crisis (Nukina et al., 2014, Paquette et al., 2011, Rubin et al., 1987, Rubin et al., 1990).